| Clarksville Health & Rehab Center | |
| 184 Buffalo Road, Clarksville, Virginia 23927 | |
| (434) 374-4141 | |
| Name | Clarksville Health & Rehab Center |
|---|---|
| Location | 184 Buffalo Road, Clarksville, Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 168 |
| Occupancy Rate | 46.31% |
| Medicare ID (CCN) | 495379 |
| Legal Business Name | Clarksville Health & Rehab Center Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1134738248 |
| Organization Name | CLARKSVILLE HEALTH & REHAB CENTER, LLC |
| Address | 184 Buffalo Rd, Clarksville, VA 23927 |
| Phone Number | 434-374-4141 |
News Archive
Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.
Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism.
It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry.
Kaiser Permanente together with the National Patient Safety Foundation and the National Association of Public Hospitals and Health Systems today announced the "Patient Safety Initiative at America's Public Hospitals." This two-year program is designed to enhance patient safety programs at public hospitals to ensure safe, high-quality care for vulnerable and low-income populations that depend on publicly supported health care institutions for medical care.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
› Verified 8 days ago
| NPI Number | 1619974029 |
| Organization Name | CLARKSVILLE SENIOR CARE, LLC |
| Doing Business As | SENTARA MEADOWVIEW TERRACE |
| Address | 184 Buffalo Rd, Clarksville, VA 23927 |
| Phone Number | 434-374-4141 |
News Archive
Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.
Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism.
It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry.
Kaiser Permanente together with the National Patient Safety Foundation and the National Association of Public Hospitals and Health Systems today announced the "Patient Safety Initiative at America's Public Hospitals." This two-year program is designed to enhance patient safety programs at public hospitals to ensure safe, high-quality care for vulnerable and low-income populations that depend on publicly supported health care institutions for medical care.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.
Using high-resolution microscopy, researchers at the National Institutes of Health have shown how insulin prompts fat cells to take in glucose in a rat model. The findings were reported in the Sept. 8 issue of the journal Cell Metabolism.
It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry.
Kaiser Permanente together with the National Patient Safety Foundation and the National Association of Public Hospitals and Health Systems today announced the "Patient Safety Initiative at America's Public Hospitals." This two-year program is designed to enhance patient safety programs at public hospitals to ensure safe, high-quality care for vulnerable and low-income populations that depend on publicly supported health care institutions for medical care.
For the first time, a team of chemists and engineers at Penn State University have placed tiny synthetic motors inside live human cells, propelled them with ultrasonic waves and steered them magnetically. It's not exactly "Fantastic Voyage," but it's close. The nanomotors, which are rocket-shaped metal particles, move around inside the cells, spinning and battering against the cell membrane.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7345 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.56 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.84 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.59 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.13 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.99 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.08 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 17.7 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.1 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.25 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.93 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.81 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.56 | 95.98 |